Navigation Links
New Breast Imaging Technology Targets Hard-to-Detect Cancers
Date:12/2/2008

CHICAGO, Dec. 3 /PRNewswire-USNewswire/ -- Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

"BSGI can identify the most difficult to detect breast cancer-invasive lobular carcinoma," said lead author Rachel F. Brem, M.D., professor of radiology and director of the Breast Imaging and Interventional Center at The George Washington University Medical Center in Washington, D.C. "It also can help us detect additional lesions of all types of breast cancer in women whose mammograms show only one suspicious lesion."

Breast cancer affects more women than any other non-skin cancer and, according to the American Cancer Society, accounts for more than 40,000 deaths annually in the U.S. Most experts agree that the best way to decrease breast cancer mortality is through early detection using mammography and clinical breast exam. However, some cancers are difficult to detect with mammography and clinical exam, particularly in the earliest stage when treatment is most effective.

While mammography findings are characterized by the difference in appearance between normal and suspicious breast tissue, BSGI findings are based on how cancerous cells function.

"It is this physiological approach to breast cancer diagnosis that allows for improved cancer detection," Dr. Brem said.

BSGI is an emerging molecular imaging technology using a high-resolution gamma camera that allows for imaging with very mild compression of the breast along with an injection of a low-dose nuclear material called a radiotracer, which is absorbed by the cells. Because cancerous cells have a higher rate of metabolic activity, the tracer is taken up by these cells at a higher level than in normal cells.

Dr. Brem and
'/>"/>

SOURCE Radiological Society of North America (RSNA)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Mammography Technology Effective in Detecting Breast Cancer
2. Siemens Introduces New Standard of Care for Breast Ultrasound
3. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
4. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
5. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
6. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
7. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
8. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
9. Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
10. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
11. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 PDL BioPharma, Inc. (PDL) (Nasdaq: ... the December 15, 2009 special dividend payment of $1.67 ... as of December 1, 2009. With this payment, ... 2009 total $2.67 per share. In January 2010, ... tax characteristics of the Company,s 2009 cash distributions and ...
(Date:12/15/2009)... -- West Pharmaceutical Services, Inc. (NYSE: WST ... approved payment of the first-quarter 2010 cash dividend of ... February 3, 2010 to shareholders of record on January ... West is a global manufacturer of components and systems ... vials, and closures and disposable components used in syringe, ...
(Date:12/15/2009)... Dec. 15 OrthoWorx, the newly formed industry, ... orthopedics device sector in Kosciusko County, is working to ... cities like Chicago and Cleveland via high-speed rail. ,, ... Indiana: The Orthopedics Capital of the World -- ... community growth, BioCrossroads, the statewide initiative to ...
Breaking Medicine Technology:PDL BioPharma Completes December 15 Special Dividend Payment 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 1Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 2Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 60982 3Book by UC Riverside biologist explains Darwins Origin of Species 60979 1Book by UC Riverside biologist explains Darwins Origin of Species 60979 2Antarctica glacier retreat creates new carbon dioxide store 10666 1Antarctica glacier retreat creates new carbon dioxide store 10666 2
... announced clinical,trial data for Seroquel sustained ... the European Congress of Psychiatry,(ECP) in ... SEROQUEL®,sustained release formulation (quetiapine fumarate sustained,release), ... with schizophrenia (measured by PANSS) and ...
... 2007 - Calando,Pharmaceuticals, a leading siRNA therapeutics ... Corporation,(NASDAQ: ARWR) announced the publication in the ... the scientific journal of the,NAS, of the ... systemic,dosing with Calando's lead siRNA therapeutic candidate ...
Other Medicine Technology:Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 2Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 3Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 5
(Date:12/16/2009)... 16 While many of the,pharma ... forecast models,for new and inmarket drugs, MarketsandMarkets ... solutions to various players. These pharma,forecasting solutions ... as well as phase,III. These have a ... cycle,management, market entry strategy, manufacturing planning, sales ...
(Date:12/16/2009)... run marathons, competed in triathalons and appeared on The ... Sarah Reinertsen likes to think of herself as part human, ... is how the 34-year-old triathlete likes to describe herself. When ... speaking to packed school auditoriums or posing nude with her ... cover of the latest ESPN Body Issue. , ...
(Date:12/16/2009)... /PRNewswire-FirstCall/ - TSO3 Inc. ("TSO3") (TSX: TOS) and ... been reached for 3M to be the exclusive ... The partnership with TSO3, an innovator in low ... settings through the use of ozone, will include ... 3M,s global sales channel. This agreement, combined with ...
(Date:12/16/2009)... a bachelor degree, an individual can begin working and become ... ... (Vocus) December 16, 2009 -- According to " Measuring ... by the National Center for Public Policy and Higher Education, ... sectors of the economy.”¹ Since 1982, the national price of ...
(Date:12/16/2009)... approaching and what would be the perfect gift to give that ... Celebrity Beauty Engineer® and Licensed Esthetician Mary Schook introduces exceptional beauty ... feel their best! , ... (PRWEB) December 16, 2009 ... does a person get that special woman who has everything? Why ...
Breaking Medicine News(10 mins):Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 2Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 3Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 4Health News:Career in Eye Care Practical Compared to Rising Tuition Costs 5Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2
... DETROIT, April 11 The McCarty Cancer,Foundation ... of,Medicine and Oncology, Barbara Ann Karmanos Cancer ... a $50,000 grant for the multi-center,Multiple Myeloma ... program, initiated by Dr. Zonder, is a ...
... April 11 Draeger was awarded with the,2007 ... This award,goes to honor the manufacturer which best ... aspects of safety, ease of use,technical features, comfort, ... The rating is given based on two ...
... Triple-negative breast cancers are a heterogeneous group and may ... new study shows. , The study of 145 triple ... progesterone receptor-negative and HER2-negative) in 128 women found that ... Mercado, MD, of New York University School of Medicine, ...
... new sonographic method in evaluating and diagnosing small bowel ... of barium enteroclysis, according to a recent study conducted ... and Research in Chandigarh, India. Sonoenteroclysis is a ... given fluid through the nasojejunal tube in order to ...
... fibroids with 3T MR-guided focused ultrasound (MRgFUS) is ... study conducted by researchers at Weill Cornell Medical ... of women in the United States have clinically ... surgical with hysterectomy or myomectomy. However, in the ...
... regarding screening mammography in elderly patients, those older than ... showing that with frequent mammograms breast cancers can be ... researchers at Jacobi Medical Center and Albert Einstein College ... interest was sparked by the changing mammographic guidelines in ...
Other Medicine News:Health News:McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute 2Health News:McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute 3Health News:Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection 2Health News:New procedure in diagnosing small bowel disorders proves efficient and effective 2Health News:Screening mammography in elderly patients beneficial 2
... is a sensitive, simple to ... the detection of all major ... can distinguish between P. ... vivax . In addition, the ...
... is a two site sandwich ... the detection of P. falciparum ... HRP-2) and P. vivax specific ... be used for specific detection ...
The Cellabs Rapimal (P.f.) is a rapid and sensitive in vitro immunochromatography assay system for the detection of HRP-2 antigen produced by P. falciparum at the merozoite (red blood cell) stage o...
An immunochromatographic rapid test for the detection of Plasmodium falciparum in whole blood....
Medicine Products: